Out of the $10.45 billion brought into the biopharma industry this year by way of collaborations with nonprofit entities or through grants, 80% is focused on COVID-19 therapeutics and vaccines.
So far in 2020, there has been a total of $5.9 billion raised through 362 grants and $4.5 billion through 515 bio/nonprofit collaborations. Of those, 137 grants worth $4.78 billion and 241 bio/nonprofit deals worth $3.57 billion are going to biopharma company efforts fighting the SARS-CoV-2 pandemic.
All around, the best month of the year money-wise has been July, which posted $1.76 billion of the grants and $2.57 billion of the bio/nonprofit partnerships. The month can boast both the largest bio/nonprofit deal for the year and the largest grant for the year, each of which are upwards of $1 billion.
During July, Biontech SE and partner Pfizer Inc. recorded a $1.95 billion agreement to supply the U.S. government with its mRNA-based vaccine, BNT-162, for COVID-19. Novavax Inc. received $1.6 billion in grant money from the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) to support development of its vaccine, NVX-CoV2373.
Other top COVID-19 grants so far this year also involved money coming from BARDA. Astrazeneca received $1.2 billion in May for AXD-1222, Emergent Biosolutions Inc. received $628 million in June to deploy its capabilities in accelerating the delivery of COVID-19 vaccines, and Moderna Therapeutics Inc. was awarded $483 million in April and another $472 million in July for the development of its vaccine, mRNA-1273.
The second and third top bio/nonprofit deals are also focused on COVID-19 vaccines, one signed in June worth $829.2 million for Astrazeneca plc to supply its COVID-19 vaccine, AZD-1222, to the European Union governments, and another signed in July worth $624 million for Sanofi SA to supply its candidate to the U.K. government.
To see bio/nonprofit deals and grants tracked by BioWorld Snapshots in 2020, visit the following links:
Biopharma financings data for 2020 through July 30 can be found here: